These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 18577930)

  • 1. [The possibilities of using himantane in the treatment of Parkinson's disease].
    Katunina EA; Petrukhova AV; Avakian GN; Val'dman EA; Nerobkova LN; Voronina TA; Saiadian KhS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):24-7. PubMed ID: 18577930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cabergoline on parkinsonian tremor assessed by long-term actigraphy.
    Binder S; Deuschl G; Volkmann J
    Eur Neurol; 2009; 61(3):149-53. PubMed ID: 19092251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A differentiated approach to Parkinson's disease treatment in early stage of the disease].
    Selikhova MV; Piatnitskiĭ AN; Aristova RA; Belikova LP; Vialkova AB; Gusev EI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(4):24-9. PubMed ID: 15270296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tremorlytic activity of budipine: a quantitative study with long-term tremor recordings.
    Spieker S; Löschmann P; Jentgens C; Boose A; Klockgether T; Dichgans J
    Clin Neuropharmacol; 1995 Jun; 18(3):266-72. PubMed ID: 8635185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An impact of pronoran on cognitive and affective disorders in Parkinson's disease].
    Pilipovich AA; Golubev VL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(4):41-7. PubMed ID: 15875942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pramipexole, a nonergot dopamine agonist, is effective against rest tremor in intermediate to advanced Parkinson's disease.
    Künig G; Pogarell O; Möller JC; Delf M; Oertel WH
    Clin Neuropharmacol; 1999; 22(5):301-5. PubMed ID: 10516884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling the Parkinson's tremor and its treatments.
    Haeri M; Sarbaz Y; Gharibzadeh S
    J Theor Biol; 2005 Oct; 236(3):311-22. PubMed ID: 15950988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes.
    Rascol O; Fitzer-Attas CJ; Hauser R; Jankovic J; Lang A; Langston JW; Melamed E; Poewe W; Stocchi F; Tolosa E; Eyal E; Weiss YM; Olanow CW
    Lancet Neurol; 2011 May; 10(5):415-23. PubMed ID: 21482191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linear and nonlinear tremor acceleration characteristics in patients with Parkinson's disease.
    Meigal AY; Rissanen SM; Tarvainen MP; Georgiadis SD; Karjalainen PA; Airaksinen O; Kankaanpää M
    Physiol Meas; 2012 Mar; 33(3):395-412. PubMed ID: 22370008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
    Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ropinirole on visuo-motor test in newly diagnosed Parkinson's disease patients.
    Badarny S; Stern A; Susel Z; Honigman S; Hocherman S
    Acta Neurol Scand; 2006 May; 113(5):294-300. PubMed ID: 16629764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating QTc in patients with advanced Parkinson's disease: overcoming artifact.
    Bloomfield DM
    Clin Pharmacol Ther; 2009 Apr; 85(4):365-6. PubMed ID: 19295536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution tracking of motor disorders in Parkinson's disease during unconstrained activity.
    Roy SH; Cole BT; Gilmore LD; De Luca CJ; Thomas CA; Saint-Hilaire MM; Nawab SH
    Mov Disord; 2013 Jul; 28(8):1080-7. PubMed ID: 23520058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tremor in Parkinson's disease: 24-hr monitoring with calibrated accelerometry.
    Thielgen T; Foerster F; Fuchs G; Hornig A; Fahrenberg J
    Electromyogr Clin Neurophysiol; 2004; 44(3):137-46. PubMed ID: 15125053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Articulation disorders and duration, severity and L-dopa dosage in idiopathic Parkinson's disease.
    Pawlukowska W; Gołąb-Janowska M; Safranow K; Rotter I; Amernik K; Honczarenko K; Nowacki P
    Neurol Neurochir Pol; 2015; 49(5):302-6. PubMed ID: 26377981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modern therapy of Parkinson's disease.
    Ransmayr G; Künig G; Gerstenbrand F
    J Neural Transm Suppl; 1992; 38():129-40. PubMed ID: 1491245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of rasagiline as adjunct therapy to levodopa on severity of OFF in Parkinson's disease.
    Stocchi F; Rabey JM
    Eur J Neurol; 2011 Dec; 18(12):1373-8. PubMed ID: 21895884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levodopa effect upon functional balance of Parkinson's disease patients.
    Nova IC; Perracini MR; Ferraz HB
    Parkinsonism Relat Disord; 2004 Oct; 10(7):411-5. PubMed ID: 15465397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Holmes' tremor in a patient with Parkinson's disease following acute cerebellar infarction.
    Kim DG; Koo YH; Kim OJ; Oh SH
    Mov Disord; 2009 Feb; 24(3):463-4. PubMed ID: 19086080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.